NCT06536881View on ClinicalTrials.gov

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 8, 2024

Primary Completion Date

August 31, 2028

Study Completion Date

May 31, 2029

Conditions
Breast CancerEarly-stage Breast Cancer
Interventions
BEHAVIORAL

Fasting

The dietician will review the patient's chemotherapy schedule, and confirm the fasting window (as windows may be 24, 26 or 48 hours; and chemotherapy start times can vary from patient to patient).

Trial Locations (1)

20016

RECRUITING

Sibley Memorial Hospital, Washington D.C.

All Listed Sponsors
collaborator

The Commonwealth Fund

OTHER

collaborator

Maryland Cigarette Restitution Fund

OTHER_GOV

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER